

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 6.24110347 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.99613623 |
| 3 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.74746125 |
| 4 | sodium ion export (GO:0071436) | 5.60928411 |
| 5 | locomotory exploration behavior (GO:0035641) | 5.38690672 |
| 6 | cellular potassium ion homeostasis (GO:0030007) | 5.28030868 |
| 7 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.04273367 |
| 8 | synaptic vesicle exocytosis (GO:0016079) | 4.94360700 |
| 9 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.89207537 |
| 10 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.86661857 |
| 11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.77956307 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.68793785 |
| 13 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.67520585 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.59975520 |
| 15 | response to pheromone (GO:0019236) | 4.58885928 |
| 16 | glutamate secretion (GO:0014047) | 4.37897432 |
| 17 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.35804170 |
| 18 | vocalization behavior (GO:0071625) | 4.35214436 |
| 19 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.26728216 |
| 20 | regulation of synaptic vesicle transport (GO:1902803) | 4.25486961 |
| 21 | neurotransmitter secretion (GO:0007269) | 4.15743056 |
| 22 | regulation of ARF protein signal transduction (GO:0032012) | 4.14923656 |
| 23 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.05823393 |
| 24 | protein localization to synapse (GO:0035418) | 4.02459971 |
| 25 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.00730697 |
| 26 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.00598949 |
| 27 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.99317774 |
| 28 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.99317774 |
| 29 | modulation by symbiont of host immune response (GO:0052553) | 3.99317774 |
| 30 | positive regulation by symbiont of host defense response (GO:0052509) | 3.99317774 |
| 31 | modulation by symbiont of host defense response (GO:0052031) | 3.99317774 |
| 32 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.99317774 |
| 33 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.93398298 |
| 34 | layer formation in cerebral cortex (GO:0021819) | 3.87713064 |
| 35 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.86330997 |
| 36 | exploration behavior (GO:0035640) | 3.83611503 |
| 37 | detection of bacterium (GO:0016045) | 3.82953504 |
| 38 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.81570661 |
| 39 | detection of other organism (GO:0098543) | 3.80083607 |
| 40 | potassium ion homeostasis (GO:0055075) | 3.77088592 |
| 41 | potassium ion import (GO:0010107) | 3.70028801 |
| 42 | regulation of synapse structural plasticity (GO:0051823) | 3.64993253 |
| 43 | retinal cone cell development (GO:0046549) | 3.64183399 |
| 44 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.62591910 |
| 45 | retinal rod cell development (GO:0046548) | 3.61694315 |
| 46 | cell communication by electrical coupling (GO:0010644) | 3.60084660 |
| 47 | tolerance induction (GO:0002507) | 3.56855468 |
| 48 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.55465318 |
| 49 | activation of protein kinase A activity (GO:0034199) | 3.53713775 |
| 50 | synaptic vesicle endocytosis (GO:0048488) | 3.51982805 |
| 51 | macrophage activation involved in immune response (GO:0002281) | 3.51569781 |
| 52 | long-term memory (GO:0007616) | 3.46987987 |
| 53 | gamma-aminobutyric acid transport (GO:0015812) | 3.46096789 |
| 54 | positive thymic T cell selection (GO:0045059) | 3.45278652 |
| 55 | regulation of gamma-delta T cell activation (GO:0046643) | 3.42524466 |
| 56 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.42212453 |
| 57 | positive regulation of synapse maturation (GO:0090129) | 3.42081895 |
| 58 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.38710864 |
| 59 | detection of light stimulus involved in visual perception (GO:0050908) | 3.38710864 |
| 60 | cellular sodium ion homeostasis (GO:0006883) | 3.38274303 |
| 61 | rhodopsin mediated signaling pathway (GO:0016056) | 3.37971038 |
| 62 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.36121570 |
| 63 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.35911570 |
| 64 | germinal center formation (GO:0002467) | 3.34679651 |
| 65 | photoreceptor cell development (GO:0042461) | 3.33770233 |
| 66 | glutamate receptor signaling pathway (GO:0007215) | 3.33181099 |
| 67 | leukocyte aggregation (GO:0070486) | 3.32562063 |
| 68 | response to muramyl dipeptide (GO:0032495) | 3.32377827 |
| 69 | synaptic transmission, glutamatergic (GO:0035249) | 3.31652277 |
| 70 | positive regulation of membrane potential (GO:0045838) | 3.31537966 |
| 71 | neurotransmitter transport (GO:0006836) | 3.31039837 |
| 72 | signal complex assembly (GO:0007172) | 3.30305984 |
| 73 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.30067523 |
| 74 | thymic T cell selection (GO:0045061) | 3.29677394 |
| 75 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 3.29058690 |
| 76 | negative regulation of cell killing (GO:0031342) | 3.27156153 |
| 77 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.27156153 |
| 78 | response to peptidoglycan (GO:0032494) | 3.26395619 |
| 79 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.24014348 |
| 80 | mannose metabolic process (GO:0006013) | 3.23922658 |
| 81 | membrane hyperpolarization (GO:0060081) | 3.19800591 |
| 82 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.19721624 |
| 83 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.19050000 |
| 84 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.18214077 |
| 85 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.16749564 |
| 86 | regulation of neurotransmitter secretion (GO:0046928) | 3.15630705 |
| 87 | eye photoreceptor cell development (GO:0042462) | 3.15239649 |
| 88 | prepulse inhibition (GO:0060134) | 3.15021659 |
| 89 | glycine transport (GO:0015816) | 3.13137987 |
| 90 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.12901140 |
| 91 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.12877462 |
| 92 | negative thymic T cell selection (GO:0045060) | 3.12821345 |
| 93 | B cell receptor signaling pathway (GO:0050853) | 3.11659563 |
| 94 | neuronal action potential propagation (GO:0019227) | 3.11333202 |
| 95 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.09688426 |
| 96 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.09462844 |
| 97 | neuromuscular process controlling posture (GO:0050884) | 3.08340447 |
| 98 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.07771439 |
| 99 | neuromuscular process controlling balance (GO:0050885) | 3.07705965 |
| 100 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.07467896 |
| 101 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.06155313 |
| 102 | dendritic spine morphogenesis (GO:0060997) | 3.05746110 |
| 103 | T cell selection (GO:0045058) | 3.04622488 |
| 104 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 3.04423448 |
| 105 | neuron-neuron synaptic transmission (GO:0007270) | 3.04051413 |
| 106 | regulation of postsynaptic membrane potential (GO:0060078) | 3.03660408 |
| 107 | membrane depolarization during action potential (GO:0086010) | 3.01950741 |
| 108 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.00409066 |
| 109 | neutrophil activation involved in immune response (GO:0002283) | 2.98914511 |
| 110 | proline transport (GO:0015824) | 2.98480393 |
| 111 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.97551418 |
| 112 | regulation of vesicle fusion (GO:0031338) | 2.97354508 |
| 113 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.96593160 |
| 114 | regulation of leukocyte degranulation (GO:0043300) | 2.95231412 |
| 115 | negative T cell selection (GO:0043383) | 2.93547979 |
| 116 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.92051936 |
| 117 | regulation of neurotransmitter levels (GO:0001505) | 2.90566597 |
| 118 | protein localization to endosome (GO:0036010) | 2.89171668 |
| 119 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.88907779 |
| 120 | positive regulation of Rap GTPase activity (GO:0032854) | 2.87710185 |
| 121 | response to laminar fluid shear stress (GO:0034616) | 2.87152892 |
| 122 | regulation of tolerance induction (GO:0002643) | 2.87067865 |
| 123 | detection of external biotic stimulus (GO:0098581) | 2.86749568 |
| 124 | regulation of neurotransmitter transport (GO:0051588) | 2.86278878 |
| 125 | mating behavior (GO:0007617) | 2.83610709 |
| 126 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.82041545 |
| 127 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.81792269 |
| 128 | regulation of ARF GTPase activity (GO:0032312) | 2.81304864 |
| 129 | dendrite morphogenesis (GO:0048813) | 2.81259464 |
| 130 | long-term synaptic potentiation (GO:0060291) | 2.78503568 |
| 131 | NIK/NF-kappaB signaling (GO:0038061) | 2.78450809 |
| 132 | response to auditory stimulus (GO:0010996) | 2.78207611 |
| 133 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.78032807 |
| 134 | axon cargo transport (GO:0008088) | 2.77966374 |
| 135 | positive regulation of neurotransmitter transport (GO:0051590) | 2.77455867 |
| 136 | innervation (GO:0060384) | 2.77329506 |
| 137 | vesicle transport along microtubule (GO:0047496) | 2.76860967 |
| 138 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.76742183 |
| 139 | response to interleukin-15 (GO:0070672) | 2.76042505 |
| 140 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.75836954 |
| 141 | membrane repolarization (GO:0086009) | 2.75065003 |
| 142 | activation of Rac GTPase activity (GO:0032863) | 2.74967277 |
| 143 | positive T cell selection (GO:0043368) | 2.72164077 |
| 144 | regulation of regulated secretory pathway (GO:1903305) | 2.72090074 |
| 145 | regulation of synaptic plasticity (GO:0048167) | 2.71667813 |
| 146 | positive regulation of vesicle fusion (GO:0031340) | 2.71160914 |
| 147 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.70921124 |
| 148 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.70556341 |
| 149 | immunoglobulin mediated immune response (GO:0016064) | 2.70176464 |
| 150 | membrane depolarization (GO:0051899) | 2.69122005 |
| 151 | regulation of mast cell degranulation (GO:0043304) | 2.68581211 |
| 152 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.64982895 |
| 153 | dopamine receptor signaling pathway (GO:0007212) | 2.64120775 |
| 154 | auditory behavior (GO:0031223) | 2.63285287 |
| 155 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.63148585 |
| 156 | L-amino acid import (GO:0043092) | 2.62502918 |
| 157 | hypotonic response (GO:0006971) | 2.61774191 |
| 158 | regulation of defense response to virus by virus (GO:0050690) | 2.61433650 |
| 159 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.59359005 |
| 160 | response to host (GO:0075136) | 2.59359005 |
| 161 | response to host defenses (GO:0052200) | 2.59359005 |
| 162 | response to type I interferon (GO:0034340) | 2.59326986 |
| 163 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.59097092 |
| 164 | photoreceptor cell maintenance (GO:0045494) | 2.58638908 |
| 165 | positive regulation of tolerance induction (GO:0002645) | 2.57951680 |
| 166 | type I interferon signaling pathway (GO:0060337) | 2.57951348 |
| 167 | cellular response to type I interferon (GO:0071357) | 2.57951348 |
| 168 | negative regulation of T cell mediated immunity (GO:0002710) | 2.56861334 |
| 169 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.56070546 |
| 170 | response to host immune response (GO:0052572) | 2.56070546 |
| 171 | cellular extravasation (GO:0045123) | 2.55387223 |
| 172 | respiratory burst (GO:0045730) | 2.54939998 |
| 173 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.53804980 |
| 174 | regulation of T cell tolerance induction (GO:0002664) | 2.51152796 |
| 175 | detection of biotic stimulus (GO:0009595) | 2.50828928 |
| 176 | modulation by symbiont of host cellular process (GO:0044068) | 2.50291554 |
| 177 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.47445823 |
| 178 | modulation by virus of host process (GO:0019054) | 2.46372991 |
| 179 | negative regulation of interleukin-12 production (GO:0032695) | 2.44829663 |
| 180 | regulation of extracellular matrix disassembly (GO:0010715) | 2.43952343 |
| 181 | negative regulation of type 2 immune response (GO:0002829) | 2.43157062 |
| 182 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.40794812 |
| 183 | positive regulation of protein dephosphorylation (GO:0035307) | 2.40352676 |
| 184 | myeloid cell activation involved in immune response (GO:0002275) | 2.37314577 |
| 185 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.35490962 |
| 186 | positive regulation of type 2 immune response (GO:0002830) | 2.35475765 |
| 187 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.34288582 |
| 188 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.32892545 |
| 189 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.32276611 |
| 190 | regulation of Rap GTPase activity (GO:0032317) | 2.31901869 |
| 191 | cellular response to interleukin-15 (GO:0071350) | 2.30696455 |
| 192 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.29407087 |
| 193 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.28347630 |
| 194 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.28347630 |
| 195 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.27927425 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.76469836 |
| 2 | DROSHA_22980978_ChIP-Seq_HELA_Human | 3.12048101 |
| 3 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.98748743 |
| 4 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.79106646 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.53130352 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.46754589 |
| 7 | * IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.41260680 |
| 8 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.35814440 |
| 9 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.32001863 |
| 10 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.30064955 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.29387015 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.27350619 |
| 13 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.25201607 |
| 14 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.24000214 |
| 15 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.17407443 |
| 16 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.14688785 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.13561096 |
| 18 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.13438522 |
| 19 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.13438522 |
| 20 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.12904049 |
| 21 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.10901318 |
| 22 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.08472436 |
| 23 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.04770430 |
| 24 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.04074963 |
| 25 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.01912960 |
| 26 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.99455777 |
| 27 | * MAF_26560356_Chip-Seq_TH1_Human | 1.98996905 |
| 28 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.95032129 |
| 29 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.92907344 |
| 30 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.92570173 |
| 31 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.88744228 |
| 32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.86291772 |
| 33 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.85794321 |
| 34 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.81691071 |
| 35 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.80245004 |
| 36 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.79917454 |
| 37 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.78372280 |
| 38 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.77996543 |
| 39 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.75549149 |
| 40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.75358162 |
| 41 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.74964166 |
| 42 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.73135341 |
| 43 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.71024188 |
| 44 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.68136354 |
| 45 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.67911897 |
| 46 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.66515796 |
| 47 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60935456 |
| 48 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.59936441 |
| 49 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.59402252 |
| 50 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.59015271 |
| 51 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.58976944 |
| 52 | MAF_26560356_Chip-Seq_TH2_Human | 1.55805354 |
| 53 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.53927835 |
| 54 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.51441317 |
| 55 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.48258363 |
| 56 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.48195460 |
| 57 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.48163940 |
| 58 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.47897466 |
| 59 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.47264890 |
| 60 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.47070415 |
| 61 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.45159475 |
| 62 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.44728534 |
| 63 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.43911943 |
| 64 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.42309685 |
| 65 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.42019714 |
| 66 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.39549794 |
| 67 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.39158641 |
| 68 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.38255875 |
| 69 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.38004995 |
| 70 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.37700204 |
| 71 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.37168710 |
| 72 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.37147333 |
| 73 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.36829757 |
| 74 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.36308362 |
| 75 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.35744857 |
| 76 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.34937629 |
| 77 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.34086094 |
| 78 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.33895697 |
| 79 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.32605484 |
| 80 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.31387881 |
| 81 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.30859567 |
| 82 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.30858496 |
| 83 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.30290734 |
| 84 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.29987518 |
| 85 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.29689865 |
| 86 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28680844 |
| 87 | MYC_22102868_ChIP-Seq_BL_Human | 1.28224881 |
| 88 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.27577179 |
| 89 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26728820 |
| 90 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.25918309 |
| 91 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.25549143 |
| 92 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.23659675 |
| 93 | AR_19668381_ChIP-Seq_PC3_Human | 1.23611629 |
| 94 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.22309007 |
| 95 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.22092215 |
| 96 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21892491 |
| 97 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.20452143 |
| 98 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.20158403 |
| 99 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.20081121 |
| 100 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.19074633 |
| 101 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.18845360 |
| 102 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.16979144 |
| 103 | SPI1_23127762_ChIP-Seq_K562_Human | 1.15894402 |
| 104 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.15521723 |
| 105 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.15492838 |
| 106 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.14607446 |
| 107 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13850593 |
| 108 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.13103147 |
| 109 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.12873907 |
| 110 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.12670227 |
| 111 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12064841 |
| 112 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.11812071 |
| 113 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.11752820 |
| 114 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.11426319 |
| 115 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10419011 |
| 116 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.09579943 |
| 117 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.08973773 |
| 118 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.08397916 |
| 119 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06995219 |
| 120 | * TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.06620813 |
| 121 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.05861268 |
| 122 | MYB_26560356_Chip-Seq_TH1_Human | 1.04748414 |
| 123 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04164040 |
| 124 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03685412 |
| 125 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.03538474 |
| 126 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.03208142 |
| 127 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.98773777 |
| 128 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.98724864 |
| 129 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.98609121 |
| 130 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.98600729 |
| 131 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.97283914 |
| 132 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.96439094 |
| 133 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96018991 |
| 134 | P68_20966046_ChIP-Seq_HELA_Human | 0.95662084 |
| 135 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.95606987 |
| 136 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.94763067 |
| 137 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.93412501 |
| 138 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92198274 |
| 139 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.91269413 |
| 140 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.87612557 |
| 141 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.86147239 |
| 142 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85561906 |
| 143 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.85398218 |
| 144 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.85366857 |
| 145 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.84886642 |
| 146 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.84380907 |
| 147 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.84130350 |
| 148 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.84094485 |
| 149 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.83626618 |
| 150 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.83473074 |
| 151 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.83462916 |
| 152 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.83182312 |
| 153 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.82823752 |
| 154 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.81958789 |
| 155 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.81696125 |
| 156 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.81033581 |
| 157 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.80537213 |
| 158 | STAT3_23295773_ChIP-Seq_U87_Human | 0.80406420 |
| 159 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.79409141 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.84931549 |
| 2 | MP0005551_abnormal_eye_electrophysiolog | 4.04600018 |
| 3 | MP0003436_decreased_susceptibility_to | 3.87512324 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.64664964 |
| 5 | MP0005423_abnormal_somatic_nervous | 3.31380906 |
| 6 | MP0009046_muscle_twitch | 2.95515379 |
| 7 | MP0003880_abnormal_central_pattern | 2.92002787 |
| 8 | MP0006072_abnormal_retinal_apoptosis | 2.79813260 |
| 9 | MP0002064_seizures | 2.77192371 |
| 10 | MP0009745_abnormal_behavioral_response | 2.74830532 |
| 11 | MP0001835_abnormal_antigen_presentation | 2.67864223 |
| 12 | MP0004270_analgesia | 2.67396683 |
| 13 | MP0002063_abnormal_learning/memory/cond | 2.64091783 |
| 14 | MP0005253_abnormal_eye_physiology | 2.48890441 |
| 15 | MP0003724_increased_susceptibility_to | 2.43859696 |
| 16 | MP0000685_abnormal_immune_system | 2.43142326 |
| 17 | MP0008569_lethality_at_weaning | 2.42949122 |
| 18 | MP0008260_abnormal_autophagy | 2.39678822 |
| 19 | MP0003705_abnormal_hypodermis_morpholog | 2.34646662 |
| 20 | MP0003011_delayed_dark_adaptation | 2.31572193 |
| 21 | MP0002419_abnormal_innate_immunity | 2.30233114 |
| 22 | MP0005451_abnormal_body_composition | 2.28963633 |
| 23 | MP0001968_abnormal_touch/_nociception | 2.25996962 |
| 24 | MP0002272_abnormal_nervous_system | 2.24624387 |
| 25 | MP0001800_abnormal_humoral_immune | 2.23114153 |
| 26 | MP0005000_abnormal_immune_tolerance | 2.22687613 |
| 27 | MP0005025_abnormal_response_to | 2.22676676 |
| 28 | MP0009278_abnormal_bone_marrow | 2.16934639 |
| 29 | MP0004947_skin_inflammation | 2.11004167 |
| 30 | MP0002572_abnormal_emotion/affect_behav | 2.09271339 |
| 31 | MP0002734_abnormal_mechanical_nocicepti | 2.06671140 |
| 32 | MP0002090_abnormal_vision | 2.06262255 |
| 33 | MP0001486_abnormal_startle_reflex | 2.05872768 |
| 34 | MP0002822_catalepsy | 2.04110500 |
| 35 | MP0002909_abnormal_adrenal_gland | 2.01736977 |
| 36 | MP0005671_abnormal_response_to | 2.01333991 |
| 37 | MP0010155_abnormal_intestine_physiology | 2.00960874 |
| 38 | MP0001502_abnormal_circadian_rhythm | 2.00343532 |
| 39 | MP0005058_abnormal_lysosome_morphology | 2.00283129 |
| 40 | MP0001849_ear_inflammation | 1.98729058 |
| 41 | MP0001501_abnormal_sleep_pattern | 1.95267489 |
| 42 | MP0002420_abnormal_adaptive_immunity | 1.94415028 |
| 43 | MP0002452_abnormal_antigen_presenting | 1.92809208 |
| 44 | MP0001819_abnormal_immune_cell | 1.92718365 |
| 45 | MP0002723_abnormal_immune_serum | 1.91944332 |
| 46 | MP0008961_abnormal_basal_metabolism | 1.90946154 |
| 47 | MP0003191_abnormal_cellular_cholesterol | 1.87638272 |
| 48 | MP0003329_amyloid_beta_deposits | 1.85109582 |
| 49 | MP0000569_abnormal_digit_pigmentation | 1.77967007 |
| 50 | MP0009780_abnormal_chondrocyte_physiolo | 1.74818429 |
| 51 | MP0006082_CNS_inflammation | 1.74282325 |
| 52 | MP0001533_abnormal_skeleton_physiology | 1.70833103 |
| 53 | MP0002229_neurodegeneration | 1.70193347 |
| 54 | MP0002067_abnormal_sensory_capabilities | 1.69531313 |
| 55 | MP0001348_abnormal_lacrimal_gland | 1.66057864 |
| 56 | MP0004510_myositis | 1.63895719 |
| 57 | MP0004811_abnormal_neuron_physiology | 1.61954275 |
| 58 | MP0005076_abnormal_cell_differentiation | 1.58917520 |
| 59 | MP0009785_altered_susceptibility_to | 1.58876303 |
| 60 | MP0001970_abnormal_pain_threshold | 1.54133440 |
| 61 | MP0002405_respiratory_system_inflammati | 1.53907711 |
| 62 | MP0001984_abnormal_olfaction | 1.53226167 |
| 63 | MP0003172_abnormal_lysosome_physiology | 1.53128026 |
| 64 | MP0002184_abnormal_innervation | 1.52024036 |
| 65 | MP0004858_abnormal_nervous_system | 1.50978579 |
| 66 | MP0005464_abnormal_platelet_physiology | 1.50282783 |
| 67 | MP0004885_abnormal_endolymph | 1.50176912 |
| 68 | MP0009333_abnormal_splenocyte_physiolog | 1.48743544 |
| 69 | MP0002882_abnormal_neuron_morphology | 1.48585889 |
| 70 | MP0003633_abnormal_nervous_system | 1.48585542 |
| 71 | MP0001440_abnormal_grooming_behavior | 1.47925398 |
| 72 | MP0003787_abnormal_imprinting | 1.47381304 |
| 73 | MP0002132_abnormal_respiratory_system | 1.46684565 |
| 74 | MP0002736_abnormal_nociception_after | 1.45529782 |
| 75 | MP0002398_abnormal_bone_marrow | 1.45107728 |
| 76 | MP0005195_abnormal_posterior_eye | 1.44882305 |
| 77 | MP0000858_altered_metastatic_potential | 1.44432369 |
| 78 | MP0000716_abnormal_immune_system | 1.44105789 |
| 79 | MP0003091_abnormal_cell_migration | 1.42968515 |
| 80 | MP0003453_abnormal_keratinocyte_physiol | 1.41023875 |
| 81 | MP0003303_peritoneal_inflammation | 1.40650860 |
| 82 | MP0002733_abnormal_thermal_nociception | 1.38720889 |
| 83 | MP0005409_darkened_coat_color | 1.38595874 |
| 84 | MP0005310_abnormal_salivary_gland | 1.37584404 |
| 85 | MP0002638_abnormal_pupillary_reflex | 1.35729294 |
| 86 | MP0002735_abnormal_chemical_nociception | 1.34790930 |
| 87 | MP0002998_abnormal_bone_remodeling | 1.34669041 |
| 88 | MP0004924_abnormal_behavior | 1.34061873 |
| 89 | MP0005386_behavior/neurological_phenoty | 1.34061873 |
| 90 | MP0009840_abnormal_foam_cell | 1.33002210 |
| 91 | MP0002148_abnormal_hypersensitivity_rea | 1.31877570 |
| 92 | MP0003879_abnormal_hair_cell | 1.31493324 |
| 93 | MP0002557_abnormal_social/conspecific_i | 1.30479341 |
| 94 | MP0003566_abnormal_cell_adhesion | 1.30066417 |
| 95 | MP0001845_abnormal_inflammatory_respons | 1.29913673 |
| 96 | MP0001873_stomach_inflammation | 1.29069570 |
| 97 | MP0003045_fibrosis | 1.22481664 |
| 98 | MP0000955_abnormal_spinal_cord | 1.19854403 |
| 99 | MP0001851_eye_inflammation | 1.19708864 |
| 100 | MP0003075_altered_response_to | 1.18633266 |
| 101 | MP0003828_pulmonary_edema | 1.16139557 |
| 102 | MP0000465_gastrointestinal_hemorrhage | 1.13585903 |
| 103 | MP0002066_abnormal_motor_capabilities/c | 1.13454060 |
| 104 | MP0000703_abnormal_thymus_morphology | 1.13375447 |
| 105 | MP0002429_abnormal_blood_cell | 1.12067150 |
| 106 | MP0000678_abnormal_parathyroid_gland | 1.12047698 |
| 107 | MP0000013_abnormal_adipose_tissue | 1.11987994 |
| 108 | MP0002722_abnormal_immune_system | 1.11663897 |
| 109 | MP0000604_amyloidosis | 1.07932822 |
| 110 | MP0003631_nervous_system_phenotype | 1.07511202 |
| 111 | MP0000490_abnormal_crypts_of | 1.07277386 |
| 112 | MP0004381_abnormal_hair_follicle | 1.05903671 |
| 113 | MP0002396_abnormal_hematopoietic_system | 1.00319757 |
| 114 | MP0004233_abnormal_muscle_weight | 1.00116486 |
| 115 | MP0005645_abnormal_hypothalamus_physiol | 1.00014387 |
| 116 | MP0000689_abnormal_spleen_morphology | 0.99649217 |
| 117 | MP0005394_taste/olfaction_phenotype | 0.98548869 |
| 118 | MP0005499_abnormal_olfactory_system | 0.98548869 |
| 119 | MP0002752_abnormal_somatic_nervous | 0.98492015 |
| 120 | MP0001324_abnormal_eye_pigmentation | 0.97715944 |
| 121 | MP0003634_abnormal_glial_cell | 0.97635445 |
| 122 | MP0004145_abnormal_muscle_electrophysio | 0.96904218 |
| 123 | MP0003300_gastrointestinal_ulcer | 0.95771242 |
| 124 | MP0008469_abnormal_protein_level | 0.93797131 |
| 125 | MP0004264_abnormal_extraembryonic_tissu | 0.90269269 |
| 126 | MP0001958_emphysema | 0.88981067 |
| 127 | MP0005646_abnormal_pituitary_gland | 0.88940791 |
| 128 | MP0005391_vision/eye_phenotype | 0.88911250 |
| 129 | MP0000778_abnormal_nervous_system | 0.88313744 |
| 130 | MP0002152_abnormal_brain_morphology | 0.86521828 |
| 131 | MP0008874_decreased_physiological_sensi | 0.86424732 |
| 132 | MP0008872_abnormal_physiological_respon | 0.86370755 |
| 133 | MP0003866_abnormal_defecation | 0.86235918 |
| 134 | MP0000751_myopathy | 0.84304395 |
| 135 | MP0003690_abnormal_glial_cell | 0.84272531 |
| 136 | MP0002653_abnormal_ependyma_morphology | 0.83859037 |
| 137 | MP0002089_abnormal_postnatal_growth/wei | 0.81740122 |
| 138 | MP0003283_abnormal_digestive_organ | 0.81575765 |
| 139 | MP0004142_abnormal_muscle_tone | 0.81187995 |
| 140 | MP0002069_abnormal_eating/drinking_beha | 0.80301748 |
| 141 | MP0002933_joint_inflammation | 0.80234699 |
| 142 | MP0001663_abnormal_digestive_system | 0.79876785 |
| 143 | MP0001545_abnormal_hematopoietic_system | 0.78925621 |
| 144 | MP0005397_hematopoietic_system_phenotyp | 0.78925621 |
| 145 | MP0005390_skeleton_phenotype | 0.78159752 |
| 146 | MP0004742_abnormal_vestibular_system | 0.72842491 |
| 147 | MP0005535_abnormal_body_temperature | 0.72327508 |
| 148 | MP0001765_abnormal_ion_homeostasis | 0.72298639 |
| 149 | MP0002166_altered_tumor_susceptibility | 0.71154202 |
| 150 | MP0003183_abnormal_peptide_metabolism | 0.69381126 |
| 151 | MP0005377_hearing/vestibular/ear_phenot | 0.68545828 |
| 152 | MP0003878_abnormal_ear_physiology | 0.68545828 |
| 153 | MP0000920_abnormal_myelination | 0.66457176 |
| 154 | MP0003632_abnormal_nervous_system | 0.66346018 |
| 155 | MP0005666_abnormal_adipose_tissue | 0.66206733 |
| 156 | MP0004185_abnormal_adipocyte_glucose | 0.66179693 |
| 157 | MP0005023_abnormal_wound_healing | 0.65747767 |
| 158 | MP0003448_altered_tumor_morphology | 0.65341120 |
| 159 | MP0004808_abnormal_hematopoietic_stem | 0.64134016 |
| 160 | MP0005167_abnormal_blood-brain_barrier | 0.63006854 |
| 161 | MP0000003_abnormal_adipose_tissue | 0.62475399 |
| 162 | MP0004130_abnormal_muscle_cell | 0.61007902 |
| 163 | MP0002877_abnormal_melanocyte_morpholog | 0.60395433 |
| 164 | MP0003795_abnormal_bone_structure | 0.58841612 |
| 165 | MP0000249_abnormal_blood_vessel | 0.58244776 |
| 166 | MP0005166_decreased_susceptibility_to | 0.58214493 |
| 167 | MP0001986_abnormal_taste_sensitivity | 0.58189625 |
| 168 | MP0004085_abnormal_heartbeat | 0.57791460 |
| 169 | MP0010386_abnormal_urinary_bladder | 0.57066205 |
| 170 | MP0001177_atelectasis | 0.55758027 |
| 171 | MP0003763_abnormal_thymus_physiology | 0.54228885 |
| 172 | MP0010234_abnormal_vibrissa_follicle | 0.53432726 |
| 173 | MP0004215_abnormal_myocardial_fiber | 0.53171589 |
| 174 | MP0003122_maternal_imprinting | 0.52763576 |
| 175 | MP0005387_immune_system_phenotype | 0.52122525 |
| 176 | MP0001790_abnormal_immune_system | 0.52122525 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 7.16257929 |
| 2 | Central scotoma (HP:0000603) | 5.68749746 |
| 3 | Abnormal rod and cone electroretinograms (HP:0008323) | 5.52214042 |
| 4 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 5.27839718 |
| 5 | Bony spicule pigmentary retinopathy (HP:0007737) | 4.99247309 |
| 6 | Eczematoid dermatitis (HP:0000976) | 4.92583644 |
| 7 | Visual hallucinations (HP:0002367) | 4.91953847 |
| 8 | Scotoma (HP:0000575) | 4.31328837 |
| 9 | Abnormality of macular pigmentation (HP:0008002) | 4.29972124 |
| 10 | Focal motor seizures (HP:0011153) | 4.19917454 |
| 11 | Myokymia (HP:0002411) | 4.17389604 |
| 12 | Focal seizures (HP:0007359) | 4.06037346 |
| 13 | Obstructive sleep apnea (HP:0002870) | 4.01075225 |
| 14 | Severe visual impairment (HP:0001141) | 3.90884889 |
| 15 | Nasal polyposis (HP:0100582) | 3.71415839 |
| 16 | Action tremor (HP:0002345) | 3.64659607 |
| 17 | Pendular nystagmus (HP:0012043) | 3.61267430 |
| 18 | Progressive cerebellar ataxia (HP:0002073) | 3.56258207 |
| 19 | Recurrent abscess formation (HP:0002722) | 3.56104044 |
| 20 | Abnormality of macrophages (HP:0004311) | 3.55210404 |
| 21 | Recurrent bacterial skin infections (HP:0005406) | 3.55044696 |
| 22 | Decreased central vision (HP:0007663) | 3.51163063 |
| 23 | Abolished electroretinogram (ERG) (HP:0000550) | 3.50884181 |
| 24 | Pigmentary retinal degeneration (HP:0001146) | 3.39085647 |
| 25 | Abnormality of the nasal mucosa (HP:0000433) | 3.32809587 |
| 26 | Supranuclear gaze palsy (HP:0000605) | 3.32803679 |
| 27 | Hemiplegia (HP:0002301) | 3.32682795 |
| 28 | Epileptic encephalopathy (HP:0200134) | 3.30087106 |
| 29 | Febrile seizures (HP:0002373) | 3.28890258 |
| 30 | Chorioretinal atrophy (HP:0000533) | 3.27946444 |
| 31 | Myositis (HP:0100614) | 3.19100963 |
| 32 | Absence seizures (HP:0002121) | 3.02667062 |
| 33 | Cellulitis (HP:0100658) | 3.00053005 |
| 34 | Depression (HP:0000716) | 2.99024458 |
| 35 | Increased IgE level (HP:0003212) | 2.98164125 |
| 36 | Dysmetric saccades (HP:0000641) | 2.90762162 |
| 37 | Posterior subcapsular cataract (HP:0007787) | 2.88408713 |
| 38 | Truncal ataxia (HP:0002078) | 2.82484104 |
| 39 | Broad face (HP:0000283) | 2.80728899 |
| 40 | Genetic anticipation (HP:0003743) | 2.78118409 |
| 41 | Gingivitis (HP:0000230) | 2.77797805 |
| 42 | Dysdiadochokinesis (HP:0002075) | 2.77277465 |
| 43 | Dyschromatopsia (HP:0007641) | 2.77268258 |
| 44 | Attenuation of retinal blood vessels (HP:0007843) | 2.76262565 |
| 45 | Type II diabetes mellitus (HP:0005978) | 2.76071555 |
| 46 | Impaired smooth pursuit (HP:0007772) | 2.74040538 |
| 47 | Orchitis (HP:0100796) | 2.73566216 |
| 48 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.73515678 |
| 49 | Macular degeneration (HP:0000608) | 2.73348358 |
| 50 | Abnormality of the lower motor neuron (HP:0002366) | 2.73045222 |
| 51 | Mutism (HP:0002300) | 2.67494303 |
| 52 | Flat acetabular roof (HP:0003180) | 2.63169595 |
| 53 | Atonic seizures (HP:0010819) | 2.63004245 |
| 54 | Postural instability (HP:0002172) | 2.62559253 |
| 55 | Mediastinal lymphadenopathy (HP:0100721) | 2.58582815 |
| 56 | Ankle clonus (HP:0011448) | 2.57939361 |
| 57 | Dialeptic seizures (HP:0011146) | 2.57131986 |
| 58 | Stridor (HP:0010307) | 2.56430741 |
| 59 | Colitis (HP:0002583) | 2.55926919 |
| 60 | Meningitis (HP:0001287) | 2.55672523 |
| 61 | Chronic obstructive pulmonary disease (HP:0006510) | 2.53025563 |
| 62 | Obstructive lung disease (HP:0006536) | 2.53025563 |
| 63 | Abnormality of binocular vision (HP:0011514) | 2.52737820 |
| 64 | Diplopia (HP:0000651) | 2.52737820 |
| 65 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.52625408 |
| 66 | Photophobia (HP:0000613) | 2.52526634 |
| 67 | Recurrent fungal infections (HP:0002841) | 2.52517995 |
| 68 | Gastrointestinal inflammation (HP:0004386) | 2.52393655 |
| 69 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.52141434 |
| 70 | Gaze-evoked nystagmus (HP:0000640) | 2.49908549 |
| 71 | Distal lower limb muscle weakness (HP:0009053) | 2.45710373 |
| 72 | Insomnia (HP:0100785) | 2.45239374 |
| 73 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.44110501 |
| 74 | Gastrointestinal infarctions (HP:0005244) | 2.43949418 |
| 75 | Recurrent sinusitis (HP:0011108) | 2.43042970 |
| 76 | Increased corneal curvature (HP:0100692) | 2.42424393 |
| 77 | Keratoconus (HP:0000563) | 2.42424393 |
| 78 | Papilledema (HP:0001085) | 2.41789334 |
| 79 | Hemiparesis (HP:0001269) | 2.41762649 |
| 80 | Hyperacusis (HP:0010780) | 2.40691297 |
| 81 | Ventricular fibrillation (HP:0001663) | 2.40405383 |
| 82 | Pustule (HP:0200039) | 2.40380815 |
| 83 | Inflammation of the large intestine (HP:0002037) | 2.40316884 |
| 84 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.40061740 |
| 85 | Generalized tonic-clonic seizures (HP:0002069) | 2.37787068 |
| 86 | Abnormal social behavior (HP:0012433) | 2.34403174 |
| 87 | Impaired social interactions (HP:0000735) | 2.34403174 |
| 88 | Dysmetria (HP:0001310) | 2.32680340 |
| 89 | Retrobulbar optic neuritis (HP:0100654) | 2.30842768 |
| 90 | Optic neuritis (HP:0100653) | 2.30842768 |
| 91 | Hemorrhage of the eye (HP:0011885) | 2.30454859 |
| 92 | Constricted visual fields (HP:0001133) | 2.29533529 |
| 93 | Interstitial pulmonary disease (HP:0006530) | 2.28413831 |
| 94 | Pointed chin (HP:0000307) | 2.26866685 |
| 95 | Macroorchidism (HP:0000053) | 2.26340126 |
| 96 | Poor eye contact (HP:0000817) | 2.25228520 |
| 97 | Gastrointestinal stroma tumor (HP:0100723) | 2.24743736 |
| 98 | Recurrent skin infections (HP:0001581) | 2.22133671 |
| 99 | Annular pancreas (HP:0001734) | 2.22100498 |
| 100 | Intention tremor (HP:0002080) | 2.20715479 |
| 101 | Recurrent otitis media (HP:0000403) | 2.20065266 |
| 102 | Malnutrition (HP:0004395) | 2.18677149 |
| 103 | Cone-rod dystrophy (HP:0000548) | 2.16754507 |
| 104 | Vasculitis (HP:0002633) | 2.14419934 |
| 105 | Abnormal eating behavior (HP:0100738) | 2.13157111 |
| 106 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.11396896 |
| 107 | Choroideremia (HP:0001139) | 2.10578575 |
| 108 | Polygenic inheritance (HP:0010982) | 2.09653504 |
| 109 | Dysostosis multiplex (HP:0000943) | 2.08948012 |
| 110 | Broad-based gait (HP:0002136) | 2.08774664 |
| 111 | Anxiety (HP:0000739) | 2.07555761 |
| 112 | Scanning speech (HP:0002168) | 2.07321770 |
| 113 | Abnormal vertebral ossification (HP:0100569) | 2.06643999 |
| 114 | Spontaneous hematomas (HP:0007420) | 2.06401093 |
| 115 | Cerebral aneurysm (HP:0004944) | 2.04351827 |
| 116 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.03399674 |
| 117 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.02279290 |
| 118 | Absent/shortened dynein arms (HP:0200106) | 2.02279290 |
| 119 | Urinary urgency (HP:0000012) | 2.00890678 |
| 120 | Emphysema (HP:0002097) | 1.98317901 |
| 121 | Recurrent viral infections (HP:0004429) | 1.97942685 |
| 122 | Slow saccadic eye movements (HP:0000514) | 1.97859294 |
| 123 | Chest pain (HP:0100749) | 1.97420977 |
| 124 | Stomatitis (HP:0010280) | 1.97142023 |
| 125 | Neoplasm of the heart (HP:0100544) | 1.96542092 |
| 126 | Spastic gait (HP:0002064) | 1.96463129 |
| 127 | Bradykinesia (HP:0002067) | 1.96019606 |
| 128 | Premature loss of primary teeth (HP:0006323) | 1.95978425 |
| 129 | Loss of speech (HP:0002371) | 1.94739372 |
| 130 | Bronchiectasis (HP:0002110) | 1.94481623 |
| 131 | Amyloidosis (HP:0011034) | 1.94360729 |
| 132 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.93585416 |
| 133 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.93547065 |
| 134 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.93547065 |
| 135 | Agammaglobulinemia (HP:0004432) | 1.93304864 |
| 136 | Recurrent cutaneous fungal infections (HP:0011370) | 1.93288728 |
| 137 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.93288728 |
| 138 | Thin bony cortex (HP:0002753) | 1.93184379 |
| 139 | Chronic otitis media (HP:0000389) | 1.93096000 |
| 140 | Urticaria (HP:0001025) | 1.92094271 |
| 141 | Progressive visual loss (HP:0000529) | 1.91905857 |
| 142 | Hand muscle atrophy (HP:0009130) | 1.91060205 |
| 143 | Spinal canal stenosis (HP:0003416) | 1.90203931 |
| 144 | Upper limb amyotrophy (HP:0009129) | 1.88558804 |
| 145 | Distal upper limb amyotrophy (HP:0007149) | 1.88558804 |
| 146 | Osteomyelitis (HP:0002754) | 1.87191811 |
| 147 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.86297095 |
| 148 | Metaphyseal cupping (HP:0003021) | 1.85596438 |
| 149 | Stereotypic behavior (HP:0000733) | 1.84386852 |
| 150 | Prolonged bleeding time (HP:0003010) | 1.84251457 |
| 151 | Torticollis (HP:0000473) | 1.83487779 |
| 152 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.83433341 |
| 153 | Neurofibrillary tangles (HP:0002185) | 1.83097022 |
| 154 | Increased cerebral lipofuscin (HP:0011813) | 1.82718625 |
| 155 | Distal lower limb amyotrophy (HP:0008944) | 1.81747780 |
| 156 | Abnormality of saccadic eye movements (HP:0000570) | 1.81527294 |
| 157 | Neuronal loss in central nervous system (HP:0002529) | 1.80049518 |
| 158 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.79538188 |
| 159 | Status epilepticus (HP:0002133) | 1.78377640 |
| 160 | Mucopolysacchariduria (HP:0008155) | 1.78283237 |
| 161 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.78283237 |
| 162 | Elfin facies (HP:0004428) | 1.77948922 |
| 163 | Abnormal ciliary motility (HP:0012262) | 1.77802424 |
| 164 | Subcapsular cataract (HP:0000523) | 1.77761704 |
| 165 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.77600379 |
| 166 | Restrictive lung disease (HP:0002091) | 1.76401385 |
| 167 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.76330099 |
| 168 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.76330099 |
| 169 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.76330099 |
| 170 | Hypercortisolism (HP:0001578) | 1.74518897 |
| 171 | Agitation (HP:0000713) | 1.74438075 |
| 172 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.74123294 |
| 173 | Growth hormone excess (HP:0000845) | 1.73023962 |
| 174 | Retinitis pigmentosa (HP:0000510) | 1.72664980 |
| 175 | Atelectasis (HP:0100750) | 1.72649522 |
| 176 | Abnormality of the fingertips (HP:0001211) | 1.72098158 |
| 177 | Pulmonary infiltrates (HP:0002113) | 1.71915884 |
| 178 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.70429279 |
| 179 | Recurrent bronchitis (HP:0002837) | 1.68694833 |
| 180 | Tetraplegia (HP:0002445) | 1.68590618 |
| 181 | Cerebral inclusion bodies (HP:0100314) | 1.67831006 |
| 182 | Encephalitis (HP:0002383) | 1.67725726 |
| 183 | Apathy (HP:0000741) | 1.65925291 |
| 184 | Lymphopenia (HP:0001888) | 1.65753284 |
| 185 | Hypoventilation (HP:0002791) | 1.65192731 |
| 186 | Bundle branch block (HP:0011710) | 1.65097207 |
| 187 | Horizontal nystagmus (HP:0000666) | 1.64153842 |
| 188 | Prolonged QT interval (HP:0001657) | 1.63932880 |
| 189 | Lower limb asymmetry (HP:0100559) | 1.63487620 |
| 190 | Amyotrophic lateral sclerosis (HP:0007354) | 1.62780414 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 3.56090861 |
| 2 | ERN1 | 3.11216689 |
| 3 | NTRK3 | 2.94345941 |
| 4 | PAK6 | 2.77778012 |
| 5 | SIK2 | 2.53789268 |
| 6 | SMG1 | 2.48229371 |
| 7 | CAMKK1 | 2.39092874 |
| 8 | RIPK1 | 2.27893575 |
| 9 | STK38 | 2.17152234 |
| 10 | SIK1 | 2.16436732 |
| 11 | MINK1 | 2.11838573 |
| 12 | MARK1 | 2.08988794 |
| 13 | MAP3K13 | 2.06283913 |
| 14 | DAPK2 | 2.04888234 |
| 15 | PRKD3 | 2.04622383 |
| 16 | EPHB1 | 2.00283517 |
| 17 | NTRK2 | 1.98169142 |
| 18 | MAP3K4 | 1.95515265 |
| 19 | KSR2 | 1.92002586 |
| 20 | PRKCH | 1.91563324 |
| 21 | EPHA4 | 1.80472418 |
| 22 | MAP2K3 | 1.74217628 |
| 23 | RIPK4 | 1.70884872 |
| 24 | FES | 1.68945038 |
| 25 | IRAK4 | 1.67384932 |
| 26 | TRIB3 | 1.64201239 |
| 27 | FGFR4 | 1.62977594 |
| 28 | BLK | 1.62105409 |
| 29 | TAOK1 | 1.59401443 |
| 30 | EPHA2 | 1.55545319 |
| 31 | CSK | 1.54364998 |
| 32 | MAP3K3 | 1.45134632 |
| 33 | ZAP70 | 1.43626776 |
| 34 | MAP3K11 | 1.43037253 |
| 35 | ALK | 1.41415929 |
| 36 | CAMKK2 | 1.39421083 |
| 37 | MAP4K1 | 1.38229956 |
| 38 | CAMK1G | 1.36243892 |
| 39 | TNK2 | 1.35544209 |
| 40 | PKN2 | 1.33804606 |
| 41 | CDK5 | 1.32937281 |
| 42 | MAP3K7 | 1.32699953 |
| 43 | PRPF4B | 1.28912342 |
| 44 | MST1R | 1.26923857 |
| 45 | SIK3 | 1.24368860 |
| 46 | TYRO3 | 1.19819908 |
| 47 | MAP3K10 | 1.19800033 |
| 48 | IRAK3 | 1.19363959 |
| 49 | MAP3K14 | 1.18263898 |
| 50 | NTRK1 | 1.15907469 |
| 51 | CDK12 | 1.15731234 |
| 52 | JAK1 | 1.15353317 |
| 53 | SGK3 | 1.14467291 |
| 54 | BTK | 1.13594640 |
| 55 | TBK1 | 1.13101172 |
| 56 | MAP2K4 | 1.10296649 |
| 57 | STK11 | 1.10293058 |
| 58 | MAP2K7 | 1.07201996 |
| 59 | MARK2 | 1.06693259 |
| 60 | RET | 1.06491545 |
| 61 | MAPK15 | 1.05411627 |
| 62 | CAMK1 | 1.03976219 |
| 63 | JAK3 | 1.02633030 |
| 64 | KSR1 | 1.01645409 |
| 65 | TTN | 0.99501886 |
| 66 | PDK1 | 0.93442391 |
| 67 | SCYL2 | 0.91117731 |
| 68 | EEF2K | 0.90701845 |
| 69 | SGK494 | 0.88872832 |
| 70 | SGK223 | 0.88872832 |
| 71 | GRK1 | 0.88466834 |
| 72 | ARAF | 0.87662754 |
| 73 | DAPK1 | 0.86108140 |
| 74 | TAOK2 | 0.86000988 |
| 75 | WNK1 | 0.85160284 |
| 76 | GRK5 | 0.84716463 |
| 77 | MAP3K2 | 0.83293845 |
| 78 | CDC42BPA | 0.82273123 |
| 79 | CSF1R | 0.81868835 |
| 80 | HIPK2 | 0.80947709 |
| 81 | PHKG2 | 0.80467100 |
| 82 | PHKG1 | 0.80467100 |
| 83 | PRKD2 | 0.80246262 |
| 84 | UHMK1 | 0.80110974 |
| 85 | SGK2 | 0.79928282 |
| 86 | CAMK1D | 0.79313763 |
| 87 | FGR | 0.77675710 |
| 88 | PINK1 | 0.77604344 |
| 89 | PRKCG | 0.76967342 |
| 90 | LMTK2 | 0.75432804 |
| 91 | DYRK1A | 0.74236094 |
| 92 | MAP3K1 | 0.71674607 |
| 93 | PTK6 | 0.71300200 |
| 94 | MAP3K12 | 0.71205805 |
| 95 | DMPK | 0.70175034 |
| 96 | CDK15 | 0.69570521 |
| 97 | FYN | 0.66880496 |
| 98 | NEK1 | 0.66401444 |
| 99 | CDK18 | 0.65831268 |
| 100 | PDPK1 | 0.65799970 |
| 101 | SGK1 | 0.65749542 |
| 102 | TESK2 | 0.65688440 |
| 103 | CAMK4 | 0.64756355 |
| 104 | LCK | 0.62919100 |
| 105 | RAF1 | 0.62425034 |
| 106 | ITK | 0.61899466 |
| 107 | MAP3K6 | 0.61738606 |
| 108 | CDK11A | 0.61585575 |
| 109 | HCK | 0.61349376 |
| 110 | JAK2 | 0.61004879 |
| 111 | TESK1 | 0.60880728 |
| 112 | BMX | 0.59545949 |
| 113 | PRKG2 | 0.59266569 |
| 114 | LYN | 0.58265181 |
| 115 | RPS6KC1 | 0.57501334 |
| 116 | RPS6KL1 | 0.57501334 |
| 117 | RPS6KA3 | 0.57430462 |
| 118 | PAK3 | 0.56907057 |
| 119 | EPHA3 | 0.56747167 |
| 120 | ICK | 0.55754361 |
| 121 | CDK14 | 0.55439248 |
| 122 | MAP2K2 | 0.55110138 |
| 123 | FGFR3 | 0.54498557 |
| 124 | MAPK12 | 0.53773952 |
| 125 | RPS6KA2 | 0.53052616 |
| 126 | MAPK11 | 0.52884347 |
| 127 | MAPK7 | 0.51119453 |
| 128 | MAPK10 | 0.50961060 |
| 129 | SYK | 0.50960525 |
| 130 | LRRK2 | 0.50726736 |
| 131 | DYRK1B | 0.50611478 |
| 132 | CDK19 | 0.50313233 |
| 133 | MTOR | 0.49095129 |
| 134 | IKBKE | 0.48540860 |
| 135 | PRKCZ | 0.46813768 |
| 136 | PAK4 | 0.46543465 |
| 137 | MAP3K8 | 0.46507449 |
| 138 | GRK6 | 0.45311507 |
| 139 | TYK2 | 0.44303861 |
| 140 | IRAK2 | 0.42449232 |
| 141 | PRKCB | 0.42222559 |
| 142 | TXK | 0.41889032 |
| 143 | PDGFRA | 0.40174909 |
| 144 | MAPK8 | 0.40011754 |
| 145 | RPS6KA6 | 0.38762417 |
| 146 | IRAK1 | 0.38568687 |
| 147 | STK10 | 0.38160209 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 3.66023601 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.92205189 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.73854458 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.40706542 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.38768919 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.21584108 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.20698476 |
| 8 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.16245276 |
| 9 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.15069736 |
| 10 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.14041153 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.04892615 |
| 12 | Long-term potentiation_Homo sapiens_hsa04720 | 1.93023716 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 1.88462212 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 1.81740614 |
| 15 | Other glycan degradation_Homo sapiens_hsa00511 | 1.81637746 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 1.76769383 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.76337266 |
| 18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.71134617 |
| 19 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.62863281 |
| 20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.60556605 |
| 21 | Allograft rejection_Homo sapiens_hsa05330 | 1.52332358 |
| 22 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.50577276 |
| 23 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.49035220 |
| 24 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.47547270 |
| 25 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.46775916 |
| 26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.45689462 |
| 27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.42589518 |
| 28 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.42201365 |
| 29 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.41940937 |
| 30 | Tuberculosis_Homo sapiens_hsa05152 | 1.39760528 |
| 31 | Renin secretion_Homo sapiens_hsa04924 | 1.39726278 |
| 32 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.38982471 |
| 33 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.38708394 |
| 34 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.34212595 |
| 35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.33138971 |
| 36 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.30686523 |
| 37 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.26119321 |
| 38 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.25422201 |
| 39 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.25227471 |
| 40 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.22932967 |
| 41 | Long-term depression_Homo sapiens_hsa04730 | 1.19986335 |
| 42 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.19955614 |
| 43 | Viral myocarditis_Homo sapiens_hsa05416 | 1.19530664 |
| 44 | Cocaine addiction_Homo sapiens_hsa05030 | 1.18282513 |
| 45 | Taste transduction_Homo sapiens_hsa04742 | 1.15322339 |
| 46 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.15035883 |
| 47 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.14609862 |
| 48 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.10714229 |
| 49 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.10601022 |
| 50 | Influenza A_Homo sapiens_hsa05164 | 1.10033169 |
| 51 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.07765684 |
| 52 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.06146688 |
| 53 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.05274964 |
| 54 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.04966899 |
| 55 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.04034460 |
| 56 | Hepatitis C_Homo sapiens_hsa05160 | 1.03231316 |
| 57 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.02398999 |
| 58 | Glioma_Homo sapiens_hsa05214 | 1.01876782 |
| 59 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.00252034 |
| 60 | Gap junction_Homo sapiens_hsa04540 | 0.99843616 |
| 61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.99570541 |
| 62 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.98020303 |
| 63 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.96625802 |
| 64 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.96415764 |
| 65 | Measles_Homo sapiens_hsa05162 | 0.95835425 |
| 66 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.93553738 |
| 67 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.92268414 |
| 68 | Hepatitis B_Homo sapiens_hsa05161 | 0.91147741 |
| 69 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.91043706 |
| 70 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.90984734 |
| 71 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.89943555 |
| 72 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.87628701 |
| 73 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.86166169 |
| 74 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.85711134 |
| 75 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.85709979 |
| 76 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.85396490 |
| 77 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.85091053 |
| 78 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.82702225 |
| 79 | Salmonella infection_Homo sapiens_hsa05132 | 0.81165767 |
| 80 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.80977376 |
| 81 | Amoebiasis_Homo sapiens_hsa05146 | 0.80761126 |
| 82 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.80658180 |
| 83 | Apoptosis_Homo sapiens_hsa04210 | 0.80522475 |
| 84 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.80060417 |
| 85 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.79810413 |
| 86 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.79485705 |
| 87 | Phagosome_Homo sapiens_hsa04145 | 0.79156809 |
| 88 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.78654301 |
| 89 | Shigellosis_Homo sapiens_hsa05131 | 0.77550025 |
| 90 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.77066825 |
| 91 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.76868991 |
| 92 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.75552373 |
| 93 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.75367230 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.75303970 |
| 95 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.74505423 |
| 96 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.73990095 |
| 97 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.73355037 |
| 98 | Circadian rhythm_Homo sapiens_hsa04710 | 0.73198646 |
| 99 | Malaria_Homo sapiens_hsa05144 | 0.73054795 |
| 100 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.72712221 |
| 101 | Endocytosis_Homo sapiens_hsa04144 | 0.70523165 |
| 102 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.70392714 |
| 103 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70382086 |
| 104 | Lysosome_Homo sapiens_hsa04142 | 0.69605459 |
| 105 | Asthma_Homo sapiens_hsa05310 | 0.69590270 |
| 106 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.67596365 |
| 107 | Insulin resistance_Homo sapiens_hsa04931 | 0.66964253 |
| 108 | Endometrial cancer_Homo sapiens_hsa05213 | 0.66865595 |
| 109 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.66222126 |
| 110 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.65840730 |
| 111 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.65644623 |
| 112 | Platelet activation_Homo sapiens_hsa04611 | 0.63843044 |
| 113 | Pertussis_Homo sapiens_hsa05133 | 0.61319572 |
| 114 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.60184306 |
| 115 | Prion diseases_Homo sapiens_hsa05020 | 0.59546845 |
| 116 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.59341768 |
| 117 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.59103183 |
| 118 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.58129574 |
| 119 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58084858 |
| 120 | Thyroid cancer_Homo sapiens_hsa05216 | 0.57313076 |
| 121 | Melanogenesis_Homo sapiens_hsa04916 | 0.56691921 |
| 122 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.56463284 |
| 123 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.56037744 |
| 124 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.55858911 |
| 125 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.55610467 |
| 126 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.55535597 |
| 127 | HTLV-I infection_Homo sapiens_hsa05166 | 0.54171714 |
| 128 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.54026480 |
| 129 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.53426074 |
| 130 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51829250 |
| 131 | Axon guidance_Homo sapiens_hsa04360 | 0.51674242 |
| 132 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.50524889 |
| 133 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50426761 |
| 134 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.50211389 |
| 135 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.49941938 |
| 136 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.49315954 |
| 137 | Colorectal cancer_Homo sapiens_hsa05210 | 0.47565337 |
| 138 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.47206624 |
| 139 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.46844717 |
| 140 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.45504201 |
| 141 | Bile secretion_Homo sapiens_hsa04976 | 0.45490916 |
| 142 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.45382554 |
| 143 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.43945685 |
| 144 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.43907113 |
| 145 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.43696531 |
| 146 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.43658333 |
| 147 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.42520020 |
| 148 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.41266920 |
| 149 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.40435635 |

